Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBNXOTCMKTS:EDTXFNASDAQ:EMBCNASDAQ:IRMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBNXBeta Bionics$14.43-7.0%$12.38$8.89▼$24.50$625.63MN/A485,216 shs435,940 shsEDTXFSpectral Medical$0.61+0.7%$0.55$0.32▼$0.65$175.06M0.216,304 shs52,489 shsEMBCEmbecta$10.72+2.0%$12.13$10.27▼$21.48$626.51M1.24462,648 shs796,519 shsIRMDIradimed$51.09-2.3%$52.24$41.69▼$63.29$649.61M0.9142,720 shs27,862 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBNXBeta Bionics0.00%+0.49%+30.47%-29.85%+1,442,999,900.00%EDTXFSpectral Medical0.00%+5.05%+8.92%+34.06%+70.56%EMBCEmbecta0.00%-10.82%-8.77%-23.97%-21.00%IRMDIradimed0.00%-5.23%-3.84%-9.16%+17.34%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBNXBeta BionicsN/AN/AN/AN/AN/AN/AN/AN/AEDTXFSpectral MedicalN/AN/AN/AN/AN/AN/AN/AN/AEMBCEmbecta4.4314 of 5 stars3.21.03.30.03.33.33.8IRMDIradimed4.8884 of 5 stars3.53.02.54.43.23.31.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBNXBeta Bionics 2.78Moderate Buy$24.8372.10% UpsideEDTXFSpectral Medical 0.00N/AN/AN/AEMBCEmbecta 2.33Hold$19.6783.46% UpsideIRMDIradimed 3.00Buy$72.0040.93% UpsideCurrent Analyst Ratings BreakdownLatest EDTXF, IRMD, BBNX, and EMBC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/23/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$15.00 ➝ $13.004/10/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$15.004/9/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBNXBeta Bionics$69.83M8.96N/AN/AN/A∞EDTXFSpectral Medical$1.18M148.36N/AN/A($0.04) per share-15.35EMBCEmbecta$1.08B0.58$2.48 per share4.32($13.23) per share-0.81IRMDIradimed$75.15M8.64$1.27 per share40.12$5.66 per share9.03Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBNXBeta BionicsN/AN/A0.00∞N/AN/AN/AN/AN/AEDTXFSpectral Medical-$11.60M-$0.07N/A∞N/A-1,245.87%N/A-351.89%8/7/2025 (Estimated)EMBCEmbecta$78.30M$0.9010.723.490.785.25%-19.22%11.92%8/8/2025 (Estimated)IRMDIradimed$19.23M$1.5534.0625.55N/A26.26%24.12%21.20%8/7/2025 (Estimated)Latest EDTXF, IRMD, BBNX, and EMBC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/9/2025Q1 2025EDTXFSpectral MedicalN/A-$0.03N/A-$0.03N/A$0.40 million5/9/2025Q2 2025EMBCEmbecta$0.66$0.70+$0.04$0.40$261.77 million$259.00 million5/6/2025Q1 2025BBNXBeta Bionics-$0.51-$0.52-$0.01-$0.93N/AN/A3/25/2025Q4 2024BBNXBeta Bionics-$0.42-$1.82-$1.40-$2.72$20.01 million$20.44 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBNXBeta BionicsN/AN/AN/AN/AN/AEDTXFSpectral MedicalN/AN/AN/AN/AN/AEMBCEmbecta$0.605.60%N/A66.67%N/AIRMDIradimed$0.681.33%N/A43.87%1 YearsLatest EDTXF, IRMD, BBNX, and EMBC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2025EMBCEmbectaquarterly$0.154.51%5/28/20255/28/20256/13/20255/5/2025IRMDIradimedquarterly$0.171.3%5/20/20255/20/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBNXBeta BionicsN/AN/AN/AEDTXFSpectral MedicalN/A0.220.21EMBCEmbectaN/A2.241.67IRMDIradimedN/A9.217.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBNXBeta BionicsN/AEDTXFSpectral MedicalN/AEMBCEmbecta93.83%IRMDIradimed92.34%Insider OwnershipCompanyInsider OwnershipBBNXBeta BionicsN/AEDTXFSpectral Medical1.50%EMBCEmbecta0.42%IRMDIradimed36.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBNXBeta Bionics29443.36 millionN/AN/AEDTXFSpectral Medical29285.12 million280.48 millionNot OptionableEMBCEmbecta1,90058.44 million57.89 millionOptionableIRMDIradimed11012.72 million7.97 millionOptionableEDTXF, IRMD, BBNX, and EMBC HeadlinesRecent News About These CompaniesNorthern Trust Corp Raises Stock Holdings in Iradimed Corporation (NASDAQ:IRMD)May 21, 2025 | marketbeat.comLazard Asset Management LLC Has $1.83 Million Stock Position in Iradimed Corporation (NASDAQ:IRMD)May 20, 2025 | marketbeat.comIradimed Corporation (NASDAQ:IRMD) Shares Bought by Dimensional Fund Advisors LPMay 12, 2025 | marketbeat.comIRADIMED CORPORATION (NASDAQ:IRMD) Released Earnings Last Week And Analysts Lifted Their Price Target To US$71.00May 9, 2025 | finance.yahoo.comBosun Asset Management LLC Has $1.17 Million Holdings in Iradimed Corporation (NASDAQ:IRMD)May 8, 2025 | marketbeat.comIradimed (NASDAQ:IRMD) Upgraded to Strong-Buy at StockNews.comMay 8, 2025 | marketbeat.comIradimed (NASDAQ:IRMD) Releases Quarterly Earnings Results, Misses Estimates By $0.06 EPSMay 7, 2025 | marketbeat.comIradimed (NASDAQ:IRMD) Releases FY 2025 Earnings GuidanceMay 7, 2025 | marketbeat.comIradimed (NASDAQ:IRMD) Issues Q2 2025 Earnings GuidanceMay 7, 2025 | marketbeat.comTudor Investment Corp ET AL Increases Stake in Iradimed Corporation (NASDAQ:IRMD)May 7, 2025 | marketbeat.comState of Tennessee Department of Treasury Takes $302,000 Position in Iradimed Corporation (NASDAQ:IRMD)May 7, 2025 | marketbeat.comIradimed Corp Bottom Line Rises In Q1May 6, 2025 | nasdaq.comIRadimed Corporation (NASDAQ:IRMD) Q1 2025 Earnings Call TranscriptMay 6, 2025 | msn.comIradimed Announces Quarterly ResultsMay 5, 2025 | baystreet.caIradimed stock surges as Q1 earnings top estimatesMay 5, 2025 | investing.comIRADIMED CORPORATION (IRMD) Q1 2025 Earnings Call TranscriptMay 5, 2025 | seekingalpha.comIRadimed (IRMD) Lags Q1 Earnings EstimatesMay 5, 2025 | zacks.comIRADIMED CORPORATION Announces First Quarter 2025 Financial ResultsMay 5, 2025 | globenewswire.comVoleon Capital Management LP Makes New Investment in Iradimed Corporation (NASDAQ:IRMD)May 4, 2025 | marketbeat.com42,170 Shares in Iradimed Corporation (NASDAQ:IRMD) Bought by Raymond James Financial Inc.May 2, 2025 | marketbeat.comCORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025April 28, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeEDTXF, IRMD, BBNX, and EMBC Company DescriptionsBeta Bionics NASDAQ:BBNX$14.43 -1.08 (-6.96%) As of 05/23/2025 04:00 PM EasternBeta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.Spectral Medical OTCMKTS:EDTXF$0.61 +0.00 (+0.66%) As of 05/23/2025 01:01 PM EasternSpectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.Embecta NASDAQ:EMBC$10.72 +0.21 (+2.00%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$10.89 +0.17 (+1.58%) As of 05/23/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.Iradimed NASDAQ:IRMD$51.09 -1.19 (-2.28%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$51.05 -0.04 (-0.08%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
